Skip To Main Content
Herprit Mahal on Muck Rack

Herprit Mahal

Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Herprit

Contact Herprit, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Therapeutic Inertia in Pharmacologic Dose Optimization: Prevalence, Clinical Consequences, and Economic Burden Across Sixteen Chronic Conditions

|
By Avik Ray, Jonathan Agnew, Herprit Mahal
| Preprints.org
You are already at the latest version Background. Therapeutic inertia — conventionally defined as the failure to initiate or intensify pharmacotherapy when clinical treatment targets are unmet and used in that under-titration sense throughout this review — is a pervasive and underappreciated source of preventable harm in ambulatory medicine.
Open in Who Shared Issue with article?
See all 1 articles